WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

D DERMATOLOGICALS

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.


D10 ANTI-ACNE PREPARATIONS

The DDDs are based on the treatment of severe acne.


D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE

This group comprises all topical preparations used specifically in the treatment of acne, incl. preparations with antibiotics, corticosteroids etc.

D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE

This group comprises drugs for systemic use in the treatment of acne. Antibiotics, such as tetracyclines and erythromycin, which are also used for the treatment of acne, are classified in group J.
Combinations of e.g. estrogen and antiandrogen, used for the treatment of acne, are classified in group G03 - Sex hormones and modulators of the genital system.

Last updated: 2024-01-26